Fast-spreading variants of the COVID-19-causing coronavirus, SARS-CoV-2, carry mutations that enable the virus to escape some of the immune response created naturally or by vaccination.
As business rework their mask requirements such as lifting face mask requirements for customers who are vaccinated against COVID-19, questions about medical privacy are back in the spotlight. The question of whether it's okay to ask a maskless patron if they've been vaccinated has come into focus. Vaccine opponents, including members of the U.S. Congress, are once again claiming that the HIPAA federal privacy law protects individuals from being asked about their vaccination status. We find this claim to be false.
How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET
Perlmutter Cancer Center at NYU Langone Health is collaborating with more than 70 other National Cancer Institute (NCI)-designated cancer centers and partner organizations to issue a joint statement urging the nation’s physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.
As the global race for COVID-19 vaccination continues, new research from the University of South Australia shows that the uptake of vaccines could be vastly improved if approved vaccine brands received more positive promotion and media coverage.
Throughout the country, states are opening up and lifting COVID-19 restrictions that have been in place for more than a year at a time when only about a third of Americans have been fully vaccinated and less than a half have received at least one dose. Perry N. Halkitis, dean of the Rutgers School of Public Health, discusses how to interpret new guidelines, what to expect in the coming months, and if this is an indication that life is returning to normal.
Sanford Burnham Prebys has joined doctors & scientists across America at National Cancer Institute (NCI)-designated cancer centers & other organizations to issue a joint statement urging the nation’s physicians, parents & young adults to get the human papillomavirus (HPV) vaccination back on track.
As part of a unanimous effort on the part of the nation’s 71 National Cancer Institute (NCI)-designated cancer centers, Roswell Park Comprehensive Cancer Center is urging the nation’s physicians, parents and young adults to get cancer-preventing human papillomavirus (HPV) vaccination back on track.
Philadelphia-Based Top Academic Health System Becomes Nation’s Largest to Mandate Vaccination, Calling for Workforce to Set an Example to End the Pandemic
If there’s one take-home message for the general public about the coronavirus vaccines approved in the U.S., it’s that they are remarkably effective. But Michigan State University’s Morteza Mahmoudi is raising awareness about an important subtlety: The vaccines developed by Moderna and Pfizer-BioNTech appear to work slightly better for men than for women.
Mayo Clinic Cancer Center has joined 71 National Cancer Institute-designated comprehensive cancer centers in calling on the nation's health care providers, parents and young adults to help get HPV vaccinations back on track. HPV causes several types of cancers, and nearly everyone gets infected with HPV by age 50.
The University of Kansas Cancer Center has partnered with 70 other National Cancer Institute (NCI)-designated cancer centers and partner organizations to issue a joint statement urging the nation’s physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.
The COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention.
A study of more than 3 million insured U.S. adult patients under 65 found that nearly 3% take immunosuppressive drugs that may elevate risk for severe COVID-19 symptoms and hospitalization if they became infected. There is growing evidence that immunosuppressive drugs may also reduce the COVID vaccine's efficacy.
DALLAS – May 20, 2021 – UT Southwestern Medical Center scientists have identified the first two cases of the B.1.617.2 (Indian origin) variant of COVID-19 infection in North Texas using next-generation sequencing technologies along with targeted PCR testing.
NEWS STORIES IN THIS ISSUE: - Case Study Suggests Young People Susceptible to Chronic Fatigue Syndrome After COVID-19 - Johns Hopkins Patient Breathes Easier After Nearly Yearlong Battle Following COVID-19 - COVID-19 Vaccine Approved for Kids 12 and Up – What to Expect
Researchers have identified specific influenza targets that could be used to better protect Indigenous people from experiencing severe influenza disease through a universal, T cell-based vaccine.
Institute of Human Virology at the University of Maryland School of Maryland scientists, who are also members of the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in 35 countries, and colleagues today published a perspective proposing that live attenuated vaccines (LAVs), such as those for tuberculosis, measles, and polio, may induce protective innate immunity that mitigate other infectious diseases, triggering the human body’s natural emergency response to infections including COVID-19 as well as future pandemic threats.
Inconsistencies, potential problems, and lack of access give researchers cause for concern's about the secretive development process.
A rare syndrome has been observed in people following vaccination against Covid-19.
2021 Alexandra Jane Noble (AJN) Awards ceremony will be virtual, held May 26. ANJ Awards recognizes science innovators
Matthew Kreuter, the Kahn Family Professor of Public Health at the Brown School, has received $1.9 million in grants to help increase COVID-19 vaccinations among Blacks in St. Louis City and County.
In a new study from Beth Israel Deaconess Medical Center researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. They found that both vaccines triggered immune responses in pregnant and lactating women.
A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what's anticipated to be the second line of defence against the virus.
A new Northwestern Medicine study of placentas from patients who received the COVID-19 vaccine during pregnancy found no evidence of injury, adding to the growing literature that COVID-19 vaccines are safe in pregnancy.
Rush staff members collaborated with Malcom X College to provide content including video scenarios and conversation advice, for a new Vaccine Ambassador Course offered to the public.
COACH for Kids® is hitting the road to help parents get their children caught up on their standard childhood vaccines.
UAB experts explain some of the benefits of getting a COVID-19 vaccine.
A single intranasal dose of a COVID-19 vaccine candidate created by Altimmune Inc. provides sterilizing immunity in the lungs of vaccinated animals. In contrast, non-vaccinated animals showed dense pulmonary infection and disease following infection with the virus that causes COVID-19.
Research from Saint Louis University finds that adult patients who have received a Tdap vaccination have a 42% lower risk for dementia, compared with patients who are not vaccinated.
An article published by Robert F. Kennedy Jr.’s anti-vaccination organization and widely shared on social media questions the need of vaccinating those who’ve already recovered from COVID-19. The article says there’s a "potential risk of harm, including death" in getting the vaccines. We report this claim as false. There is no evidence that vaccinating people who had previously had COVID is resulting in an increased risk of adverse events.
By: Bill Wellock | Published: May 7, 2021 | 11:55 am | SHARE: President Joe Biden has expressed his support for a World Trade Organization proposal to waive intellectual property rights for COVID-19 vaccines.Florida State University law professor Frederick Abbott, the Edward Ball Eminent Scholar Professor of International Law, is available to comment on international intellectual property rights and global economic issues around the proposal.
Rutgers has been selected as a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children ages 6 months to 11 years. This is the third time Rutgers has served as a COVID-19 vaccine clinical trial site for pharmaceutical companies. Last fall, it conducted trials for Moderna and Johnson & Johnson.
Many CSU campuses now offer even more options for students and employees to get their COVID-19 shots, thanks to unique partnerships with national pharmacies and local hospitals.
With around 30 percent of the U.S. population now fully vaccinated, the rate of daily vaccinations has started to slow, raising concerns that greater efforts and investments may be needed to reach higher coverage levels.
St. Jude Children’s Research Hospital COVID-19 screening and vaccination program for employees offers early evidence that vaccine protects against asymptomatic infection, which has fueled the pandemic.
How Can Scientists Predict a COVID-19 Outbreak? There's an App for that; Johns Hopkins Medicine Collaborates with the City and Faith Organizations to Offer Guidance on Safely Reopening Houses of Worship; Johns Hopkins Hospital Patient ‘Grateful to Still Be Alive’ After Two-Month Hospitalization with COVID-19; “12 Things You Need To Know” Infographic...
Some women who have gotten vaccinated for COVID-19 have noticed a startling development ― lumps that in the past might have meant cancer. But Penn State Health experts say that temporary swelling of the lymph nodes is normal and expected.
In a study published today in the Journal of the American Medical Association (JAMA), Johns Hopkins Medicine researchers show that although two doses of a vaccine against SARS-CoV-2 — the virus that causes COVID 19 — confers some protection for people who have received solid organ transplants, it’s still not enough to enable them to dispense with masks, physical distancing and other safety measures.
Since the beginning of the pandemic, herd immunity has been portrayed as the holy grail to overcome the COVID-19 pandemic.
SEATTLE — May 4, 2021 — Below are summaries of recent Fred Hutch research findings and other news.If you are covering news at the upcoming American Society of Gene & Cell Therapy, American Society of Clinical Oncology, or other conferences, feel free to reach out to our media team for help sourcing experts: media@fredhutch.
Mayo Clinic data scientists have added a vaccination tracker to Mayo's COVID-19 Resource Center, with state-by-state data and trends, so users can follow the COVID-19 vaccine rollout in all 50 states, compare progress on one- and two-shot vaccinations, and receive Mayo Clinic guidance on what the trends mean for summer travel and keeping your family safe.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right